Hiroyuki Takeda
No ORCID on file
· 1 paper in corpus
other
2016
A phase 2 clinical trial investigating the efficacy and safety of AS602801, a newly developed JNK inhibitor, in the treatment of inflammatory endometriosis is complete. We are now examining whether AS602801 acts against human cancer cells i…